Back to Search
FARROW DURANT, MD
MD
Pediatrics Physician
NPI: 1245421056Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
201065(LA)
Research & Publications (20)
New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
PMID 19469474·J Med Chem·2009
8-other
Structure-based pharmacophore of COX-2 selective inhibitors and identification of original lead compounds from 3D database searching method.
PMID 17030482·Eur J Med Chem·2006
8-other
Structural insights into human 5-lipoxygenase inhibition: combined ligand-based and target-based approach.
PMID 16392803·J Med Chem·2006
7-preclinical
A new potential cyclooxygenase-2 inhibitor, pyridinic analogue of nimesulide.
PMID 16225966·Eur J Med Chem·2005
8-other
Use of specific functionalised tips with STM: a new identification method of ester groups and their molecular structure in self-assembled overlayers.
PMID 15861482·Chemistry·2005
8-other
New COX-2/5-LOX inhibitors: apoptosis-inducing agents potentially useful in prostate cancer chemotherapy.
PMID 15566290·J Med Chem·2004
7-preclinical
1-[4-(Methylsulfonyl)phenyl]-5-phenyl-1H-pyrazole derivatives.
PMID 15345845·Acta Crystallogr C·2004
8-other
Three 5H-indeno[1,2-c]pyridazin-5-one derivatives, potent type-B monoamine oxidase inhibitors.
PMID 15345837·Acta Crystallogr C·2004
8-other
Rational approaches towards reversible inhibition of type B monoamine oxidase. Design and evaluation of a novel 5H-Indeno[1,2-c]pyridazin-5-one derivative.
PMID 12467619·Bioorg Med Chem Lett·2003
8-other
Spectral and crystallographic study of pyridinic analogues of nimesulide: determination of the active form of methanesulfonamides as COX-2 selective inhibitors.
PMID 12408728·J Med Chem·2002
7-preclinical
Comparison of 3D structures and AT(1) binding properties of pyrazolidine-3,5-diones and tetrahydropyridazine-3,6-diones with parent antihypertensive drug irbesartan.
PMID 12361407·J Med Chem·2002
4-observational
N-tert-butyl-N'-(2-cyclohexylamino-5-nitrobenzenesulfonyl)urea, BM531, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition.
PMID 12359948·Acta Crystallogr C·2002
8-other
Metal-organic compounds: a new approach for drug discovery. N1-(4-methyl-2-pyridyl)-2,3,6-trimethoxybenzamide copper(II) complex as an inhibitor of human immunodeficiency virus 1 protease.
PMID 12034371·Biochem Pharmacol·2002
8-other
Structural approach of the mechanism of inhibition of alpha-chymotrypsin by coumarins.
PMID 11909728·Bioorg Med Chem Lett·2002
8-other
Pyrazolidine-3,5-dione angiotensin-II receptor antagonists.
PMID 11706265·Acta Crystallogr C·2001
8-other
Synthesis and structural analysis of the copper(II) complexes of N2-(2-pyridylmethyl)-2-pyridinecarboxamide.
PMID 11566326·J Inorg Biochem·2001
8-other
Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor.
PMID 11370706·J Pharm Pharmacol·2001
7-preclinical
Structure determination and comparison of BM567, a sulfonylurea, with terbogrel, two compounds with dual action, thromboxane receptor antagonism and thromboxane synthase inhibition.
PMID 11327579·Bioorg Med Chem Lett·2001
4-observational
Isosterism among analogues of torasemide: conformational, electronic and lipophilic properties.
PMID 11121618·Eur J Med Chem·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2713 DANTZLER DR
NORTH CHARLESTON, SC 29406 - Phone
- (843) 764-1722
Quick Facts
- NPI
- 1245421056
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile